Life stress and adherence to antiretroviral therapy among HIV-positive individuals: A preliminary investigation

AIDS Patient Care and STDs

Volumn 19, Issue 11, 2005, Pages 719-727

  Bottonari, Kathryn A ^a   Roberts, John E ^a   Ciesla, Jeffrey A ^b   Hewitt, Ross G ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BISEXUALITY; CAUCASIAN; CLINICAL ARTICLE; DEPRESSION; DISEASE SEVERITY; ETHNOLOGY; FEMALE; GENDER; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFE EVENT; LYMPHOCYTE COUNT; MALE; NEUROSIS; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RISK FACTOR; SELF ESTEEM; SEXUAL INTERCOURSE; STRESS; SYMPTOMATOLOGY; TREATMENT OUTCOME; VIRUS LOAD;

ADULT; ANTI-RETROVIRAL AGENTS; DEPRESSIVE DISORDER; FEMALE; HIV INFECTIONS; HUMANS; LIFE CHANGE EVENTS; MALE; PATIENT COMPLIANCE; QUESTIONNAIRES; SELF CONCEPT; STRESS, PSYCHOLOGICAL; VIRAL LOAD;

EID: 28244435736     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2005.19.719     Document Type: Article

References (43)

1. Cohen S, Williamson GR. Stress and infectious disease in humans. Psychol Bull 1991;109:5-24.
2. Kelly B, Raphael B, Judd F, et al. Psychiatric disorder in HIV infection. Aust NZ J Psychiatry 1998;32:441-453.
3. Leserman J, Petitto JM, Gu H, et al. Progression to AIDS, a clinical AIDS condition and mortality: Psychosocial and physiological predictors. Psychol Med 2002;32:1059-1073.
4. Carpenter CC, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1998: Updated recommendations of the International AIDS Society-USA Panel. JAMA 1998;280:78-86.
5. Siegel K, Karus D, Dean L. Psychosocial characteristics of New York City HIV-infected women before and after the advent of HAART. Am J Public Health 2004;94:1127-1132.
6. Carpenter CC, Cooper DA, Fischl MA, et al. Antiretroviral therapy in adults: Updated recommendations of the International AIDS Society-USA Panel. JAMA 2000;283:381-390.
7. Yeni PG, Hammer SM, Carpenter CCJ, et al. Antiretroviral treatment for adult HIV infection in 2002: Updated recommendations of the International AIDS Society-USA Panel. JAMA 2002;288:222-235.
8. Chesney MA, Morin M, Sherr L. Adherence to HIV combination therapy. Soc Sci Med 2000;50:1599-1605.
9. Deeks SG, Smith M, Holodniy M, Kahn JO. HIV-1 protease inhibitors: A review for clinicians. JAMA 1997;277:145-153.
10. Carmona A, Knobel H, Guelar A, et al. Factors influencing survival in HIV infected patients treated with HAART. Presented at 13th International AIDS Conference. Durban, South Africa, July 9-14, 2000.
11. Walsh JC, Hertogs K, Gazzard B. Viral drug adherence and pharmacokinetic indices in HIV-1 infected patients on successful and failing protease inhibitor (PI) based highly active antiretroviral therapy (HAART). Presented at the 40th Interscience Conference of Antimicrobial Agents and Chemotherapy. Toronto, Canada, September 17-20, 2000.
12. Hewitt R, Roberts JE, Shelton MJ, Esch LD. Psychological factors and future adherence to antiretroviral therapy. Poster presented at the 1st International AIDS Society Conference on HIV Pathogenesis and Treatment. Buenos Aires, Argentina, July 8-11, 2000.
13. Crandall CS, Coleman R. AIDS-related stigmatization and the disruption of social relationships. J Soc Pers Relat 1992;9:163-177.
14. Lyter D, Valdiserri R, Kingsley L, Amoroso W, Rinaldo C. The HIV antibody test: Why gay and bisexual men want or do not want to know their results. Public Health Rep 1987;102:468-474.
15. Siegel K. AIDS: The social dimension. Psychiatr Ann 1986;16:168-172.
16. Safren SA, Gershuny BS, Hendriksen E. Symptoms of posttraumatic stress and death anxiety in persons with HIV and medication adherence difficulties. AIDS Patient Care STDs 2003;17:657-664.
17. Katz S, Nevid JS. Risk factors associated with posttraumatic stress disorder symptomatology in HIV-infected women. AIDS Patient Care STDs 2005;19:110-120.
18. Dohrenwend BS, Dohrenwend BP. Stressful Life Events: Their Nature and Effects. Oxford, England: John Wiley & Sons, 1974.
19. Dohrenwend BS, Dohrenwend BP. Stressful Life Events and their Contexts. New York: Prodist, 1981.
20. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983;24:385-396.
21. Murphy DA, Greenwell L, Hoffman D. Factors associated with antiretroviral adherence among HIV-infected women with children. Women Health 2002; 36:97-111.
22. Mellins CA, Kang E, Leu C, Havens JF, Chesney MA. Longitudinal study of mental health and psychosocial predictors of medical treatment adherence in mothers living with HIV Disease. AIDS Patient Care STDs 2003;17:407-416.
23. Brown GW, Harris TO. Social Origins of Depression: A Study of Psychiatric Disorder in Women. New York: Free Press, 1978.
24. Lewinsohn PM, Hoberman HM, Rosenbaum M. A prospective study of risk factors for unipolar depression. J Abnorm Psychol 1988;97:251-264.
25. Monroe SM, Depue RA. Life stress and depression. In Becker J, Kleinman A, eds. Psychosocial Aspects of Depression. Hillsdale, NJ: Lawrence Erlbaum Associates, Inc., 1991:101-130.
26. Ostrow DG. Behavioral Aspects of AIDS. New York: Plenum Press, 1991.
27. Roberts JE, Ciesla JA, Direnfeld D, Hewitt RG. Emotional distress among HIV-positive individuals: The roles of acute negative life events and psychological diatheses. Pers Individ Dif 2001;30:241-257.
28. Delahanty DL, Bogart LM, Figler JL. Posttraumatic stress disorder symptoms, salivary cortisol, medication adherence, and CD4 levels in HIV-positive individuals. AIDS Care 2004;16:247-260.
29. Weaver KE, Antoni MH, Lechner SC, et al. Perceived stress mediates the effects of coping on the quality of life of HIV-positive women on highly active antiretroviral therapy. AIDS Behav 2004;8:175-182.
30. New York State Department of Health HIV/AIDS Quarterly Update-March 1998. www.health.state.ny. us/nysdoh/aids/quarterlyupdate/03-1998/bufffalo. htm (Last accessed March 30, 2005).
31. Zimmerman M, Coryell W, Corenthal C, Wilson S. A self-report scale to diagnose major depressive disorder. Arch Gen Psychiatry 1986;43:1076-1081.
32. Rosenberg M. Society and the Adolescent Self-image. Princeton, NJ: Princeton University Press, 1965.
33. Eysenck SBG, Eysenck HJ, Barrett P. A revised version of the psychoticism scale. Pers Individ Dif 1985;6:21-29.
34. Sarason IG, Johnson JH, Siegel JM. Assessing the impact of life changes: Development of the life experiences survey. J Consult Clin Psychol 1978;46:932-946.
35. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21-30.
36. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2004.
37. Fox J. Effects: Effect Displays for Linear and Generalized Linear Models. R package version 1.0-5 www. r-project.org 2004. (Last accessed March 30, 2005).
38. Aiken LS, West SG. Multiple Regression: Testing and Interpreting Interactions. Newbury Park, CA: Sage, 1991.
39. Ciesla JA, Roberts JE. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry 2001;158:725-730.
40. Hammen CL. Generation of stress in the course of unipolar depression. J Abnorm Psychol 1991;100:555-561.
41. Magnus K, Diener E, Fujita F, Pavot W. Extraversion and neuroticism as predictors of objective life events: A longitudinal analysis. J Pers Soc Psychol 1993;65:1036-1053.
42. Evans DL, Ten Have TR, Douglas SD, et al. Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection. Am J Psychiatry 2002;159:1752-1759.
43. Monroe SM, Roberts JE. Conceptualizing and measuring life stress: Problems, principles, procedures, progress. Stress Med 1990;6:209-216.